Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffen, S. C.
Right arrow Articles by German, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffen, S. C.
Right arrow Articles by German, M. S.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:63-68, 2001
© 2001 by the American Diabetes Association, Inc.

A Genetic Defect in ß-Cell Gene Expression Segregates Independently From the fa Locus in the ZDF Rat

Steven C. Griffen, Juehu Wang, and Michael S. German

From the Hormone Research Institute (S.C.G., J.W., M.S.G) and the Department of Medicine (S.C.G., M.S.G.), University of California, San Francisco, California.

Address correspondence and reprint requests to Michael S. German, MD, HSW 1090, Box 0534, 513 Parnassus Ave., San Francisco, CA 94143. E-mail: mgerman{at}biochem.ucsf.edu .

Type 2 diabetes is a strongly genetic disorder resulting from inadequate compensatory insulin secretion in the face of insulin resistance. The Zucker diabetic fatty (ZDF) rat is a model of type 2 diabetes and, like the human disease, has both insulin resistance (from a mutant leptin receptor causing obesity) and inadequate ß-cell compensation. To test for an independently inherited ß-cell defect, we examined ß-cell function in fetuses of ZDF-lean rats, which have wild-type leptin receptors. ß-Cell number and insulin content do not differ among wild-type, heterozygous, and homozygous ZDF-lean fetuses. However, insulin promoter activity is reduced 30-50% in homozygous ZDF-lean fetal islets, and insulin mRNA levels are similarly reduced by 45%. This is not a generalized defect in gene expression nor an altered transfection efficiency, because the islet amyloid polypeptide promoter and viral promoters are unaffected. Insulin promoter mapping studies suggest that the defect involves the critical A2-C1-E1 region. This study demonstrates that the ZDF rat carries a genetic defect in ß-cell transcription that is inherited independently from the leptin receptor mutation and insulin resistance. The genetic reduction in ß-cell gene transcription in homozygous animals likely contributes to the development of diabetes in the setting of insulin resistance.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca
Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L.-X. Li, P. E. MacDonald, D. S. Ahn, G. Y. Oudit, P. H. Backx, and P. L. Brubaker
Role of Phosphatidylinositol 3-Kinase{gamma} in the {beta}-Cell: Interactions with Glucagon-Like Peptide-1
Endocrinology, July 1, 2006; 147(7): 3318 - 3325.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Kjorholt, M. C. Akerfeldt, T. J. Biden, and D. R. Laybutt
Chronic Hyperglycemia, Independent of Plasma Lipid Levels, Is Sufficient for the Loss of {beta}-Cell Differentiation and Secretory Function in the db/db Mouse Model of Diabetes
Diabetes, September 1, 2005; 54(9): 2755 - 2763.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
K. E Garnett, P. Chapman, J. A Chambers, I. D Waddell, and D. S W Boam
Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation
J. Mol. Endocrinol., August 1, 2005; 35(1): 13 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. L. Winter, J. S. Lange, M. G. Davis, G. S. Gerwe, T. R. Downs, K. G. Peters, and B. Kasibhatla
A Nonspecific Phosphotyrosine Phosphatase Inhibitor, Bis(maltolato)oxovanadium(IV), Improves Glucose Tolerance and Prevents Diabetes in Zucker Diabetic Fatty Rats
Experimental Biology and Medicine, March 1, 2005; 230(3): 207 - 216.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. R. Laybutt, H. Kaneto, W. Hasenkamp, S. Grey, J.-C. Jonas, D. C. Sgroi, A. Groff, C. Ferran, S. Bonner-Weir, A. Sharma, et al.
Increased Expression of Antioxidant and Antiapoptotic Genes in Islets That May Contribute to {beta}-Cell Survival During Chronic Hyperglycemia
Diabetes, February 1, 2002; 51(2): 413 - 423.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.